Social engagement
Social engagement: 514 social following, 1 post in the last 12 months — below the industry typical range.
Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Accelerator & incubator | 1 | 50% |
| Other / undisclosed | 1 | 50% |
Early stage biotech developing antivirals (HIV and HPV) and onco drugs based on CDK Inhibitors
Social engagement: 514 social following, 1 post in the last 12 months — below the industry typical range.
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Accelerator & incubator | 1 | 50% |
| Other / undisclosed | 1 | 50% |